• Reset filters

consultation
Publications Nov 08, 2022

New unfair contract term laws in Australia introduce large financial penalties

Significant changes to the unfair contract term provisions in the Australian Consumer Law, including potential financial penalties, will soon apply.

biotech
Publications Nov 09, 2022

Are you patent ready? IP guidance for life sciences researchers

Whether you are an academic or industry-based researcher, the question is the same: when is the right time to file a patent application?

cells
News Sep 26, 2022

Griffith Hack sponsors Fragment-Based Drug Discovery Down Under Conference 2022

Griffith Hack is proud to sponsor the 2022 edition of the Fragment-Based Drug Discovery Down Under Conference.

Insights Aug 10, 2022

Karen Sinclair talks synthetic biology on the From Idea to Intellectual Property podcast

Karen Sinclair joins host Lisa Leong on the From Idea to Intellectual Property podcast series to discuss the emerging trends and key issues in the area of synthetic biology.

Publications Jun 01, 2022

Spotlight Series: Regenerative Medicine – Part 2

Welcome to the second article of our Spotlight Series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.

Publications Apr 06, 2022

Changes to how influencers can promote therapeutic goods in Australia

The Therapeutic Goods Administration has set out new guidelines that govern how influencers can promote products on social media in return for payment or free products or services from brands.

advanced manufacturing
Publications Mar 30, 2022

Federal Budget 2022: What’s in it to accelerate Australia’s innovation agenda?

We discuss the key measures in Australia’s 2022-23 federal budget that could help drive innovation, research commercialisation and business growth.

Publications Mar 07, 2022

From idea to inception and beyond: Important learnings from female biotech founders

Female biotech founders took centre-stage at AusBiotech 2021 with the leaders of some of Australia’s most innovative start-ups coming together to discuss their experiences in the commercial scientific world.

research team
Publications Mar 04, 2022

Saving grace: Options if you disclose your invention without a patent application 

Publicly disclosing new technology before a patent application has been filed can jeopardise patent coverage – but there are options available to you in the event of disclosure.

cells
Publications Mar 02, 2022

Virus filtration patent gets clean bill of health

In a recent decision of the Australian Patent Office, a patent application directed to a membrane for filtering biological products was upheld following opposition.

tablets
Publications Jan 28, 2022

Extending the 12-month grace period for filing patent applications – what you need to know

Can the 12-month grace period for filing your patent application be extended? Yes, it can – but subject to the facts.

biotech
Publications Oct 27, 2021

Why are embryonic stem cells not able to be patented in Australia?

Despite not being specifically excluded under s18 of the Australian Patents Act, technology utilising embryonic stem cells is not able to be patented in Australia. Why is this so?

chemistry
Publications Oct 20, 2021

Spotlight Series: Regenerative Medicine – Part 1

The first in a five-part series on one of the most exciting frontiers of scientific research and innovation, regenerative medicine.

research
Publications Aug 04, 2021

Draft roadmap for Australian regenerative medicine released for comment

AusBiotech has released a draft strategic roadmap for a new regenerative medicine Catalyst.

dna research
Publications Jul 02, 2021

Guidance on patenting diagnostics in Australia: Ariosa Diagnostics v Sequenom

Federal Court confirms that a non-invasive diagnostic test for prenatal conditions is patentable subject matter in Australia.

research
Publications Nov 18, 2020

Ono: Broader is not always better

Why is patent term extension is so important to companies developing and commercialising new pharmaceutical substances?

cells
Publications Jul 17, 2018

CRISPR-Cas9 Update: Collision of Trends in IP and Life Sciences

CRISPR-Cas9 genome editing may not just be the greatest scientific breakthrough of this century, but also provides many lessons on patenting life science technologies.